Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson's Disease.

Daniel Rees, Amy L Beynon, Mariah J Lelos, Gaynor A Smith, Luke D Roberts, Lyndsey Phelps, Stephen B Dunnett, Alwena H Morgan, Rowan M Brown, Timothy Wells, Jeffrey S Davies

Cellular and molecular neurobiology 2023 Jul

filter terms:

The feeding-related hormone, acyl-ghrelin, protects dopamine neurones in murine 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-based models of experimental Parkinson's disease (PD). However, the potential protective effect of acyl-ghrelin on substantia nigra pars compacta (SNpc) dopaminergic neurones and consequent behavioural correlates in the more widely used 6-hydroxydopamine (6-OHDA) rat medial forebrain bundle (MFB) lesion model of PD are unknown. To address this question, acyl-ghrelin levels were raised directly by mini-pump infusion for 7 days prior to unilateral injection of 6-OHDA into the MFB with assessment of amphetamine-induced rotations on days 27 and 35, and immunohistochemical analysis of dopaminergic neurone survival. Whilst acyl-ghrelin treatment was insufficient to elevate food intake or body weight, it attenuated amphetamine-induced circling behaviour and SNpc dopamine neurone loss induced by 6-OHDA. These data support the notion that elevating circulating acyl-ghrelin may be a valuable approach to slow or impair progression of neurone loss in PD. © 2022. The Author(s).

Citation

Daniel Rees, Amy L Beynon, Mariah J Lelos, Gaynor A Smith, Luke D Roberts, Lyndsey Phelps, Stephen B Dunnett, Alwena H Morgan, Rowan M Brown, Timothy Wells, Jeffrey S Davies. Acyl-Ghrelin Attenuates Neurochemical and Motor Deficits in the 6-OHDA Model of Parkinson's Disease. Cellular and molecular neurobiology. 2023 Jul;43(5):2377-2384